These results help PlexusDx clinicians understand your natural GLP-1 capacity and recommend Semaglutide, Tirzepatide, or combination therapies most likely to succeed for your unique biology
An amount of 20 L of D9-trimethylamine-DCl, 8 L of ammonia, and 120 L of ethyl bromoacetate (20 mg/mL), all procured from Merck, were added
PlexusDx uses your peptide-pathway genetic insights to personalize your entire tirzepatide routine, moving beyond one-size-fits-all dosing protocols
Combined with Ginkgo Biloba, Resveratrol and vitamins D, A, E C, B12, our lutein with bilberry blend offers a holistic approach to eye care
Ongoing research highlights the potential of combination therapies and emerging agents that address immune response, inflammation, and fibrosis, offering hope for improved long-term outcomes in PBC management